Literature DB >> 7369319

Pupillary dilatation with single eyedrop mydriatic combinations.

L Apt, A Henrick.   

Abstract

We studied the mydiatic effect of three solutions containing a combination of two mydriatic drugs in 80 adult patients. The solutions tested were cyclopentolate HCl 0.5% with phenylephrine 2.5%, tropicamide 0.5% with phenylephrine 2.5%, and tropicamide 1.0% with phenylephrine 2.5%. We evaluated the effect of prior instillation of proparacaine 0.5% eyedrops. All three mydriatic combination solutions evaluated produced pupillary dilatation of about 7 mm within 60 minutes. Additional pupillary dilatation of 1 mm occurred when proparacaine was instilled before the mydriatic combination eyedrop. Mydriasis was resistant to bright light during indirect ophthalmoscopy in all patients. Pupils of younger patients dilated better than those of older patients, but sex and iris color were factors in the amount of pupillary dilatation obtained. Wide and sustained pupillary dilatation can be obtained for satisfactory indirect ophthalmoscopy by the instillation of one drop of proparacaine solution followed by a single drop of any of the three mydriatic combination solutions evaluated. By eliminating the need for multiple instillations of drugs, the use of a single eyedrop mydriatic combination is convenient in terms of time saved and also lessens the change of systemic drug toxicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7369319     DOI: 10.1016/0002-9394(80)90065-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Factors affecting pupil size after dilatation: the Twin Eye Study.

Authors:  C J Hammond; H Snieder; T D Spector; C E Gilbert
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

2.  Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation.

Authors:  James C Liu; Wesley Green; Gregory P Van Stavern; Susan M Culican
Journal:  Can J Ophthalmol       Date:  2017-08       Impact factor: 1.882

3.  Dilate the pupil and see the fundus.

Authors:  C I Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

4.  Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Authors:  Manuel Saenz-de-Viteri; Patricia Fernández-Robredo; Elisa de Nova; Elvira Bonet-Farriol; Alfonso L Sabater; Javier Zarranz-Ventura; Josemaria Caire; Luis M Sádaba; Angel Salinas-Alamán; Alfredo García-Layana
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

5.  Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

Authors:  Matt H Oltmanns; Sandeep S Samudre; Ivan G Castillo; Alireza Hosseini; Aron H Lichtman; Robert C Allen; Frank A Lattanzio; Patricia B Williams
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

6.  Comparison of two drug combinations for dilating dark irides.

Authors:  Heather A Anderson; Kimberly C Bertrand; Ruth E Manny; Ying-Sheng Hu; Karen D Fern
Journal:  Optom Vis Sci       Date:  2010-02       Impact factor: 1.973

7.  Effect of the single-drop mydriatic combination of 0.8% tropicamide with 5% phenylephrine with multiple applications of the same drop: a randomized controlled trial.

Authors:  Jitendra Jethani; Himanshu Solanki; Amod Nayak
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

8.  Randomised controlled single-blind study of conventional versus depot mydriatic drug delivery prior to cataract surgery.

Authors:  Vincent Dubois; Nadia Wittles; Meon Lamont; Simon Madge; Jon Luck
Journal:  BMC Ophthalmol       Date:  2006-11-27       Impact factor: 2.209

9.  Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial.

Authors:  Adisak Trinavarat; Auengporn Pituksung
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

10.  Assessing the Clinical Requirement of 2.5% Phenylephrine for Diagnostic Pupil Examination.

Authors:  Junsang Cho; Brent Bruck; James C Liu; Susan M Culican
Journal:  J Ocul Pharmacol Ther       Date:  2021-03-08       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.